INDIANAPOLIS - Indiana will receive $1.1 million in a settlement with Pfizer Inc. over its marketing of the drugs Zyvox and Lyrica.
Indiana Attorney General Greg Zoeller said Wednesday that the $1.1 million is Indiana's share of a $42.9 million settlement Pfizer reached to resolve allegations that the company unlawfully promoted those drugs.
Thirty-two states and the District of Columbia claimed that Pfizer used deceptive practices in marketing Zyvox, an antibacterial agent, and promoted off-label uses for Lyrica, which is used to treat fibromyalgia.
"Off-label marketing can put patients unnecessarily at risk," Zoeller said in a news release. "Pharmaceutical companies are required to only promote a prescription drug for uses that have been approved by the FDA."
Under the settlement, Pfizer is not admitting wrongdoing but said it will reform how it markets the drugs.